Advertisement

Topics

Setback in Biocon/Mylan’s biosimilar programme after GMP inspection

05:05 EDT 11 Aug 2017 | Generics and Biosimilars Initiative

Biocon/Mylan’s biosimilar programme has hit a stumbling block after failing an inspection by the French inspecting authority (L’Agence nationale de sécurité du médicament et des produits de santé: ANSM).

Original Article: Setback in Biocon/Mylan’s biosimilar programme after GMP inspection

NEXT ARTICLE

More From BioPortfolio on "Setback in Biocon/Mylan’s biosimilar programme after GMP inspection"

Quick Search
Advertisement
 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...